New data confirms Pfizer vaccine efficacious among kids ages 5 to 11
According to recent clinical data by Pfizer-BioNTech, their COVID-19 vaccine was found to be efficacious against the viral disease based on close to 9 million doses administered to kids aged 5 to 11.
First published in the journal Morbidity and Mortality Weekly Report, the data was released by the CDC.
“The report was based on data collected by the agency’s Vaccine Adverse Reporting System (VAERS). It relies on smartphone messages from parents and other guardians of children to alert the CDC of any health events occurring after a child’s vaccination,” a CDC report reads.
“More severe effects were exceedingly rare. Out of about 8.7 million vaccinations delivered during the study period, 100 such reports were received by VAERS. They included 29 reports of fever, 21 reports of vomiting, and 10 serious reports of seizure, although in some of these seizure cases, other underlying factors were potentially involved.”
The authors of the CDC report have stressed the following in a news release: “His advice? Please have your 5- to 11-year-old children vaccinated as soon as possible. This is the best way to keep them (and their families) safe and well during the ongoing pandemic.”